What is the current Botanical and Herbal Drug market size?

The Botanical and Herbal Drug market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Botanical and Herbal Drug market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Botanical and Herbal Drug market?

Rising consumer awareness and growing demand for natural products are key drivers of the market.

What are the major challenges facing the Botanical and Herbal Drug market?

Regulatory hurdles and quality control issues are major challenges facing the market.

Which regions are leading the Botanical and Herbal Drug market?

North America and Europe are leading the market, with Asia Pacific expected to grow rapidly.

Who are the top companies in the Botanical and Herbal Drug market?

Top companies include Herbalife, Blackmores, and Bayer, among others.

What future opportunities exist in the Botanical and Herbal Drug market?

Emerging markets and online sales channels present significant future opportunities.

How is technology impacting the Botanical and Herbal Drug market?

Technology is improving manufacturing processes and enabling online sales and marketing.

What is the current regulatory landscape for the Botanical and Herbal Drug market?

The regulatory landscape is evolving, with increasing scrutiny of product safety and efficacy.

What is the future outlook for the Botanical and Herbal Drug market?

The future outlook is positive, with growing demand and increasing investment in research and development.

Botanical and Herbal Drug - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Botanical and Herbal Drug by Application (Cardiovascular, Tumor, Respiratory System, Other), by Types (Prescription Drug, OTC), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Botanical and Herbal Drug Market Size | CAGR 7.8 Forecast 2033

Botanical and Herbal Drug - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Botanical and Herbal Drug Market Overview

The Botanical and Herbal Drug market refers to the industry that utilizes plant-based ingredients to develop pharmaceutical products, which are increasingly relevant in modern medicine due to their perceived safety and efficacy. As the Botanical and Herbal Drug market size continues to expand, driven by a favorable growth outlook and optimistic market forecast, the industry is poised for significant industry expansion. The scope of this market encompasses various segments, including herbal extracts, botanicals, and phytochemicals, which are used in diverse applications such as traditional medicine, dietary supplements, and pharmaceuticals. The current Botanical and Herbal Drug market size is estimated to be around $35 billion, with a projected growth forecast of 7-8% CAGR over the next five years, driven by macro drivers such as increasing consumer awareness of natural products, advancements in technology, and supportive regulatory frameworks.

Loading chart…

Key forces shaping the Botanical and Herbal Drug market include technology shifts towards more efficient extraction and processing methods, regulations that support the development and marketing of botanical drugs, and changing consumer behavior that favors natural and sustainable products. The largest region for the Botanical and Herbal Drug market is currently Asia-Pacific, while the fastest-growing region is expected to be North America, driven by increasing demand for natural and organic products. As the industry continues to evolve, driven by these key forces and trends, it is essential for stakeholders to stay informed about the latest developments and shifts in the market to remain competitive and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	21.88 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Buchang Pharmaceuticals; China TCM; Tsumura; Schwabe; Tong Ren Tang; Jumpcan Pharmaceutical; Guangzhou Baiyunshan Pharmaceutical; Yunnan Baiyao; Tasly Holding Group; Bionorica Se; Huarun 999; Taiji; Weleda; Kwangdong; GW Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Botanical and Herbal Drug market is experiencing significant growth, driven by increasing consumer preference for natural and organic products. The market dynamics are influenced by various factors, including technological advancements, regulatory frameworks, and shifting consumer demand.

Growth Drivers2 items

Rising awareness about the benefits of botanical and herbal products, leading to increased adoption and driving the Botanical and Herbal Drug market size

Advancements in extraction technology and formulation development, enabling the creation of more effective and consistent botanical and herbal products, which is expected to contribute to the growth forecast

Restraints2 items

Stringent regulatory requirements and variability in regulations across different regions, posing challenges for manufacturers and impacting the Botanical and Herbal Drug market

Limited standardization and quality control measures in the industry, affecting the consistency and efficacy of botanical and herbal products, and hindering market growth

Opportunities2 items

Growing demand for personalized and preventive healthcare, creating opportunities for botanical and herbal product manufacturers to develop targeted and effective solutions, driving the Botanical and Herbal Drug market size

Increasing focus on sustainability and eco-friendliness, enabling companies to capitalize on the trend by developing environmentally responsible botanical and herbal products, and contributing to the growth forecast

Challenges2 items

Intense competition in the Botanical and Herbal Drug market, with numerous players operating in the space, making it challenging for companies to differentiate themselves and maintain market share

Supply chain disruptions and raw material shortages, affecting the production and availability of botanical and herbal products, and impacting the overall market growth

Market Segmentation

Loading chart…

The Application segment of the Botanical and Herbal Drug market is divided into various subtypes, including pharmaceuticals, food and beverages, and cosmetics. This segmentation contributes significantly to the overall market size, as different applications have distinct requirements and preferences. For instance, pharmaceutical applications require rigorous testing and regulatory approvals, whereas food and beverages focus on taste, texture, and nutritional value. Understanding these differences is crucial for Botanical and Herbal Drug segmentation, as it enables manufacturers to tailor their products to specific industries and consumer needs.

The Types segment of the Botanical and Herbal Drug market encompasses a range of subtypes, such as herbal extracts, essential oils, and decoctions. Each subtype has its unique characteristics, production processes, and market demand. For example, herbal extracts are widely used in pharmaceuticals and dietary supplements, while essential oils are commonly used in aromatherapy and cosmetics. Analyzing these subtypes is essential for market taxonomy, as it helps identify trends, opportunities, and challenges in the Botanical and Herbal Drug market.

Botanical and Herbal Drug Segmentation Breakdown8 items

Application

Cardiovascular

Tumor

Respiratory System

Other

Types

Prescription Drug

OTC

Regional Insights

Loading chart…

The Botanical and Herbal Drug market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and Latin America being the fastest-growing region. Key drivers for North America include increased adoption of herbal supplements, favorable policies supporting the use of botanicals, and growing investments in research and development. In Europe, drivers include rising demand for natural products, established infrastructure for herbal drug manufacturing, and mature ecosystem for botanical research.

In Asia Pacific, key drivers include large demographics with a preference for traditional medicine, government initiatives supporting the use of herbal drugs, and growing infrastructure for botanical research. Latin America's growth is driven by increasing awareness of herbal supplements, expanding distribution channels, and favorable regulatory environment. The Middle East & Africa region is driven by growing demand for natural products, investments in healthcare infrastructure, and rising adoption of herbal drugs.

Regional Forecast3 items

Asia Pacific: largest region, driven by large demographics and government initiatives

Latin America: fastest-growing region, driven by increasing awareness and favorable regulatory environment

North America and Europe: established infrastructure and mature ecosystem for botanical research

Competitive Landscape

The Botanical and Herbal Drug market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Botanical and Herbal Drug competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves. Key competitive levers include product innovation, distribution networks, and regulatory approvals.

Companies in this market are adopting strategies such as M&A, partnerships, product launches, and R&D to stay competitive. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To differentiate themselves, companies are focusing on technology, service models, channel strength, customization, and cost advantages. The following companies are pursuing distinct strategies:

Buchang Pharmaceuticals: regional expansion

China TCM: vertical integration

Tsumura: premium pricing

Schwabe: OEM tie-ups

Tong Ren Tang: innovation pipeline

Jumpcan Pharmaceutical: local manufacturing

Key Botanical and Herbal Drug Companies15 items

Buchang Pharmaceuticals

China TCM

Tsumura

Schwabe

Tong Ren Tang

Jumpcan Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical

Yunnan Baiyao

Tasly Holding Group

Bionorica Se

Huarun 999

Taiji

Weleda

Kwangdong

GW Pharmaceuticals

Market Ecosystem

The Botanical and Herbal Drug ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of botanical and herbal drug products. The ecosystem boundaries are defined by the interactions between these participants, influencing how value flows through the system.

Raw material suppliers — provide botanical ingredients

OEMs / manufacturers — produce herbal drug products

Technology providers — offer extraction and processing technologies

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish quality and safety standards

Service providers / after-sales — support product development and testing

End users / buyers — purchase and use botanical and herbal drug products

In the Botanical and Herbal Drug ecosystem, control points are primarily held by regulators and standards bodies, influencing adoption through approvals and compliance requirements. Dependency risks arise from input constraints, such as raw material availability, and standards, which can impact production and distribution. Switching costs and partnerships are also critical, as companies may need to adapt to changing regulatory requirements or form alliances to access new technologies or markets. A thorough value chain analysis is necessary to understand these dynamics and navigate the ecosystem effectively.

Recent Industry Insights

The Botanical and Herbal Drug industry trends have witnessed significant developments over the last 12-18 months, driven by increasing consumer demand for natural and organic products. Recent partnerships between key players have focused on research and development of new herbal formulations, while mergers and acquisitions have led to consolidation and expansion of product portfolios. Notable product launches include innovative herbal supplements and botanical-based cosmetics, catering to the growing demand for wellness and self-care products.

Regulatory changes, such as updated guidelines for good manufacturing practices, have also impacted the industry. Furthermore, a shift in consumer trends towards sustainable and eco-friendly products has prompted companies to invest in environmentally responsible sourcing and production methods. Funding rounds and expansions have enabled companies to scale up their operations and explore new markets, driving growth in the Botanical and Herbal Drug industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Botanical and Herbal Drug market outlook. The market attractiveness is moderate, driven by increasing consumer preference for natural products. Competitive intensity is high, with numerous players competing for market share. The long-term outlook is promising, with growing demand for botanical and herbal drugs in the pharmaceutical and healthcare industries.

The innovation landscape is characterized by ongoing research and development in new product formulations and delivery systems. Demand-supply balance is expected to be stable, with key players investing in capacity expansion. However, key risk factors include regulatory challenges and supply chain disruptions. Overall, the market is poised for growth, driven by increasing adoption of botanical and herbal products.

11 items

1. Executive Summary

2. Botanical and Herbal Drug Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Botanical and Herbal Drug Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Botanical and Herbal Drug Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cardiovascular

6.1.2. Tumor

6.1.3. Respiratory System

6.1.4. Other

6.2. Global Botanical and Herbal Drug Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Prescription Drug

6.2.2. OTC

6.3. Global Botanical and Herbal Drug Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Botanical and Herbal Drug Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Botanical and Herbal Drug Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Botanical and Herbal Drug Market Competition by Key Manufacturers

8.1. Global Botanical and Herbal Drug Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Botanical and Herbal Drug: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Buchang Pharmaceuticals

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. China TCM

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Tsumura

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Schwabe

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Tong Ren Tang

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Jumpcan Pharmaceutical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Guangzhou Baiyunshan Pharmaceutical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Yunnan Baiyao

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Tasly Holding Group

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bionorica Se

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Huarun 999

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Taiji

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Weleda

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Kwangdong

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. GW Pharmaceuticals

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Botanical and Herbal Drug Market

Figure 4: Global Botanical and Herbal Drug Market: Drivers

Figure 5: Global Botanical and Herbal Drug Market: Challenges

Figure 6: Global Botanical and Herbal Drug Market: Trends

Figure 7: Global Botanical and Herbal Drug Market: Opportunity

Figure 8: Global Botanical and Herbal Drug Market: Restraint

Figure 9: Global Botanical and Herbal Drug Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Botanical and Herbal Drug Market Value (USD Million) By Region

Figure 15: Global Botanical and Herbal Drug Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Botanical and Herbal Drug Market Value (USD Million) By Region

Figure 23: Global Botanical and Herbal Drug Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Botanical and Herbal Drug Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Botanical and Herbal Drug Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Botanical and Herbal Drug Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Botanical and Herbal Drug Market Value (USD Million) By Region

Table 10: Global Botanical and Herbal Drug Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Botanical and Herbal Drug Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Botanical and Herbal Drug Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Botanical and Herbal Drug Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Buchang Pharmaceuticals Basic Information And Sales Area

Table 31: Buchang Pharmaceuticals. Products Portfolio

Table 32: China TCM Basic Information And Sales Area

Table 33: China TCM. Products Portfolio

Table 34: Tsumura Basic Information And Sales Area

Table 35: Tsumura. Products Portfolio

Table 36: Schwabe Basic Information And Sales Area

Table 37: Schwabe. Products Portfolio

Table 38: Tong Ren Tang Basic Information And Sales Area

Table 39: Tong Ren Tang. Products Portfolio

Table 40: Jumpcan Pharmaceutical Basic Information And Sales Area

Table 41: Jumpcan Pharmaceutical. Products Portfolio

Table 42: Guangzhou Baiyunshan Pharmaceutical Basic Information And Sales Area

Table 43: Guangzhou Baiyunshan Pharmaceutical. Products Portfolio

Table 44: Yunnan Baiyao Basic Information And Sales Area

Table 45: Yunnan Baiyao. Products Portfolio

Table 46: Tasly Holding Group Basic Information And Sales Area

Table 47: Tasly Holding Group. Products Portfolio

Table 48: Bionorica Se Basic Information And Sales Area

Table 49: Bionorica Se. Products Portfolio

Table 50: Huarun 999 Basic Information And Sales Area

Table 51: Huarun 999. Products Portfolio

Table 52: Taiji Basic Information And Sales Area

Table 53: Taiji. Products Portfolio

Table 54: Weleda Basic Information And Sales Area

Table 55: Weleda. Products Portfolio

Table 56: Kwangdong Basic Information And Sales Area

Table 57: Kwangdong. Products Portfolio

Table 58: GW Pharmaceuticals Basic Information And Sales Area

Table 59: GW Pharmaceuticals. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Botanical and Herbal Drug Market Value (USD Million) By Region

Table 65: Global Botanical and Herbal Drug Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Botanical and Herbal Drug Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	21.88 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Buchang Pharmaceuticals; China TCM; Tsumura; Schwabe; Tong Ren Tang; Jumpcan Pharmaceutical; Guangzhou Baiyunshan Pharmaceutical; Yunnan Baiyao; Tasly Holding Group; Bionorica Se; Huarun 999; Taiji; Weleda; Kwangdong; GW Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options